https://orcid.org/0000-0002-0849-9147
Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kimberly M. Thompson & Kamran Badizadegan. (2022) Health economic analyses of secondary vaccine effects: a systematic review and policy insights. Expert Review of Vaccines 21:3, pages 297-312.
Read now
Read now
Articles from other publishers (11)
Yang Liu, Simon R. Procter, Carl A. B. Pearson, Andrés Madriz Montero, Sergio Torres-Rueda, Elias Asfaw, Benjamin Uzochukwu, Tom Drake, Eleanor Bergren, Rosalind M. Eggo, Francis Ruiz, Nicaise Ndembi, Justice Nonvignon, Mark Jit & Anna Vassall. (2023) Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries. BMC Medicine 21:1.
Crossref
Crossref
Dinara Baiguissova, Andrea Laghi, Assel Rakhimbekova, Ildar Fakhradiyev, Aigerim Mukhamejanova, Galina Battalova, Shynar Tanabayeva, Samat Zharmenov, Timur Saliev & Galina Kausova. (2023) An economic impact of incorrect referrals for MRI and CT scans: A retrospective analysis. Health Science Reports 6:3.
Crossref
Crossref
Ranin Soliman, Jason Oke, Iman Sidhom, Nickhill Bhakta, Nancy S. Bolous, Nourhan Tarek, Sonia Ahmed, Hany Abdelrahman, Emad Moussa, Manal Zamzam, Mohamed Fawzy, Wael Zekri, Hanafy Hafez, Mohamed Sedky, Mahmoud Hammad, Hossam Elzomor, Sahar Ahmed, Madeha Awad, Sayed Abdelhameed, Enas Mohsen, Lobna Shalaby, Wael Eweida, Sherif Abouelnaga, Alaa Elhaddad & Carl Heneghan. (2023) Cost-effectiveness of childhood cancer treatment in Egypt: lessons to promote high-value care in a resource-limited setting based on real-world evidence. eClinicalMedicine 55, pages 101729.
Crossref
Crossref
Esther E Freeman, Nicole C McCann, Aggrey Semeere, Krishna P Reddy, Miriam Laker-Oketta, Helen Byakwaga, Pamela P Pei, Maya E Hajny Fernandez, Samson Kiprono, Naftali Busakhala, Jeffery N Martin, Toby Maurer, Ingrid V Bassett, Kenneth A Freedberg & Emily P Hyle. (2022) Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis. The Lancet Global Health 10:8, pages e1179-e1188.
Crossref
Crossref
Minah Park, Kelvin Bryan Tan, Shawn Vasoo, Borame L. Dickens, David Lye & Alex R. Cook. (2022) Estimated Health Outcomes and Costs Associated With Use of Monoclonal Antibodies for Prevention or Mitigation of SARS-CoV-2 Infections. JAMA Network Open 5:4, pages e225750.
Crossref
Crossref
H. Alsdurf, B. Empringham, C. Miller & A. Zwerling. (2021) Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review. BMC Infectious Diseases 21:1.
Crossref
Crossref
Carrie B Dolan, Samuel A Agyemang, Brian Clare, Charles Coleman, Bill Richter, Emily Robertson & Justice Nonvignon. (2021) Cost-effectiveness of paediatric surgery: an economic evaluation of World Paediatric Project surgical interventions in St. Vincent and the Grenadines (2002–2019). BMJ Open 11:12, pages e050286.
Crossref
Crossref
Chathika Krishan Weerasuriya, Rebecca Claire Harris, Matthew Quaife, Christopher Finn McQuaid, Richard G. White & Gabriela B. Gomez. (2021) Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis. Vaccines 9:3, pages 245.
Crossref
Crossref
Kimberly M. Thompson & Dominika A. Kalkowska. (2021) An Updated Economic Analysis of the Global Polio Eradication Initiative. Risk Analysis 41:2, pages 393-406.
Crossref
Crossref
Dominika A. Kalkowska & Kimberly M. Thompson. (2021) Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019–2029. Risk Analysis 41:2, pages 364-375.
Crossref
Crossref
Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, Anthony Culyer, Karl Claxton, Ijeoma Edoka, Amanda Glassman, Noemi Kreif, Iain Jones, Andrew J. Mirelman, Mardiati Nadjib, Alec Morton, Ole Frithjof Norheim, Jessica Ochalek, Shankar Prinja, Francis Ruiz, Yot Teerawattananon, Anna Vassall & Alexander Winch. (2020) What next after GDP-based cost-effectiveness thresholds?. Gates Open Research 4, pages 176.
Crossref
Crossref